Blood Donor Incentives across 63 Countries: The BEST Collaborative Study

IF 2.7 2区 医学 Q2 HEMATOLOGY
Caroline Graf , Krystal Oteng-Attakora , Eamonn Ferguson , Ralph Vassallo , Eva-Maria Merz , the Biomedical Excellence for Safer Transfusion Collaborative
{"title":"Blood Donor Incentives across 63 Countries: The BEST Collaborative Study","authors":"Caroline Graf ,&nbsp;Krystal Oteng-Attakora ,&nbsp;Eamonn Ferguson ,&nbsp;Ralph Vassallo ,&nbsp;Eva-Maria Merz ,&nbsp;the Biomedical Excellence for Safer Transfusion Collaborative","doi":"10.1016/j.tmrv.2023.150809","DOIUrl":null,"url":null,"abstract":"<div><p>Incentives for blood donors are a much-debated strategy intended to ensure a sufficient supply of blood. Yet, there is a fundamental lack of knowledge about which incentives are offered by different blood collectors. We provide a comprehensive description of incentive policies for whole blood donors across 63 countries and 50 states of the United States. We collected data on incentive policies by conducting 2 surveys among representatives of blood collection establishments. Additionally, we integrated incentive data from an existing study and the World Health Organization (WHO). Lastly, we performed a web content analysis of blood collector websites and news releases to extend incentive data for the United States as well as underrepresented regions. We present descriptive analyses illustrating the type and value of incentives and their geographical distribution around the globe. Approximately half of the countries in our sample employ financial incentives, which include cash and tax benefits, but also less conventional incentives, such as healthcare supplements and raffles. Time off work is also commonly offered to blood donors and varies across blood collection establishments in duration and whether it is granted to all donors or only to those whose employer allows it. There is a geographical clustering of incentives, such that neighboring countries are more likely to employ similar incentives. This study provides insights into the strategies used for incentivizing blood donation and highlights the global diversity of incentive policies for whole blood donors. In stark contrast to WHO guidelines, half of the countries surveyed employ some kind of high-value incentive for blood donors. More realistic guidelines that are adapted to the local cultural and institutional context may be needed to maintain an adequate blood supply.</p></div>","PeriodicalId":56081,"journal":{"name":"Transfusion Medicine Reviews","volume":"38 2","pages":"Article 150809"},"PeriodicalIF":2.7000,"publicationDate":"2023-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0887796323000998/pdfft?md5=f9c3e85f6457186ae3b38d55b3d3d844&pid=1-s2.0-S0887796323000998-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transfusion Medicine Reviews","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0887796323000998","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Incentives for blood donors are a much-debated strategy intended to ensure a sufficient supply of blood. Yet, there is a fundamental lack of knowledge about which incentives are offered by different blood collectors. We provide a comprehensive description of incentive policies for whole blood donors across 63 countries and 50 states of the United States. We collected data on incentive policies by conducting 2 surveys among representatives of blood collection establishments. Additionally, we integrated incentive data from an existing study and the World Health Organization (WHO). Lastly, we performed a web content analysis of blood collector websites and news releases to extend incentive data for the United States as well as underrepresented regions. We present descriptive analyses illustrating the type and value of incentives and their geographical distribution around the globe. Approximately half of the countries in our sample employ financial incentives, which include cash and tax benefits, but also less conventional incentives, such as healthcare supplements and raffles. Time off work is also commonly offered to blood donors and varies across blood collection establishments in duration and whether it is granted to all donors or only to those whose employer allows it. There is a geographical clustering of incentives, such that neighboring countries are more likely to employ similar incentives. This study provides insights into the strategies used for incentivizing blood donation and highlights the global diversity of incentive policies for whole blood donors. In stark contrast to WHO guidelines, half of the countries surveyed employ some kind of high-value incentive for blood donors. More realistic guidelines that are adapted to the local cultural and institutional context may be needed to maintain an adequate blood supply.

63 个国家的献血者激励措施:BEST 合作研究
对献血者的激励是一项备受争议的策略,旨在确保充足的血液供应。然而,人们对不同采血机构提供的激励措施缺乏了解。我们全面介绍了 63 个国家和美国 50 个州对全血献血者的激励政策。我们通过对采血机构代表进行两次调查,收集了有关激励政策的数据。此外,我们还整合了现有研究和世界卫生组织(WHO)的激励数据。最后,我们对采血机构网站和新闻发布进行了网络内容分析,以扩展美国以及代表性不足地区的激励数据。我们进行了描述性分析,说明了激励措施的类型和价值及其在全球的地理分布。在我们的样本中,约有一半的国家采用了经济激励措施,其中包括现金和税收优惠,但也有不太常规的激励措施,如医疗保健补助和抽奖。向献血者提供工休时间也很常见,不同采血机构的工休时间长短不一,而且是否向所有献血者提供工休时间,还是只向那些雇主允许的献血者提供工休时间,也不尽相同。激励措施在地域上有一定的聚集性,比如邻国更有可能采用类似的激励措施。这项研究深入探讨了激励献血的策略,并强调了全球全血献血者激励政策的多样性。与世界卫生组织的指导方针形成鲜明对比的是,半数受访国家对献血者采取了某种高价值激励措施。为保持充足的血液供应,可能需要制定更切合当地文化和制度背景的指导方针。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Transfusion Medicine Reviews
Transfusion Medicine Reviews 医学-血液学
CiteScore
11.60
自引率
0.00%
发文量
40
审稿时长
21 days
期刊介绍: Transfusion Medicine Reviews provides an international forum in English for the publication of scholarly work devoted to the various sub-disciplines that comprise Transfusion Medicine including hemostasis and thrombosis and cellular therapies. The scope of the journal encompasses basic science, practical aspects, laboratory developments, clinical indications, and adverse effects.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信